All patients, n=49 | CLI absent, n=32 | CLI present, n=17 | p Value | |
---|---|---|---|---|
Age, years | 63±11 | 64±10 | 60±14 | 0.25 |
Male gender, % | 78 | 78 | 76 | 0.89 |
Body surface area, m2 | 1.97±0.23 | 1.98±0.22 | 1.95±0.26 | 0.64 |
Body mass index, kg/m2 | 26±4 | 27±4 | 26±3 | 0.38 |
Dyslipidaemia, % | 41 | 38 | 47 | 0.52 |
Hypertension, % | 43 | 44 | 41 | 0.86 |
Diabetes, % | 8 | 9 | 6 | 0.66 |
History of CAD, % | 8 | 6 | 12 | 0.51 |
Atrial fibrillation, % | 14 | 13 | 18 | 0.62 |
NYHA class, % | ||||
I | 31 | 34 | 24 | 0.86 |
II | 43 | 41 | 47 | |
III | 22 | 22 | 23 | |
IV | 4 | 3 | 6 | |
Creatinine, mg/dL | 1.0±0.2 | 1.0±0.2 | 1.0±0.2 | 0.66 |
Medical therapy, % | ||||
ACE inhibitors/ARBs | 43 | 44 | 41 | 0.86 |
β-blockers | 33 | 34 | 29 | 0.73 |
Diuretics | 24 | 25 | 24 | 0.90 |
Surgical variables | ||||
Bypass time, min | 72±29 | 71±30 | 74±28 | 0.72 |
Flail leaflet, % | 61 | 59 | 65 | 0.71 |
Posterior leaflet prolapsing segments | ||||
Single scallop, % | 57 | 44 | 82 | 0.007 |
Multiple scallops, % | 43 | 56 | 18 | |
Valve repair, % | 98 | 97 | 100 | 0.35 |
ARB, angiotensin receptor blocker; CAD, coronary artery disease; CLI, cleft-like indentation; NYHA class, New York Heart Association functional class.